WorldStage– Clinoscope Services Limited, a substantial shareholder in Neimeth International Pharmaceuticals Plc, has acquired an additional 40,000,000 ordinary shares in the pharmaceutical manufacturing company.
According to an insider share dealing notification filed with the Nigerian Exchange Limited (NGX) and signed by Company Secretary Chinenye S. Adekanmbi on August 8, 2026, the transaction was executed on August 4, 2026, in Lagos.
Transaction Breakdown
Insider / Substantial Shareholder: Clinoscope Services Limited
Issuer: Neimeth International Pharmaceuticals Plc (ISIN: NGNEIMETH001)
Volume Purchased: 40,000,000 ordinary shares
Transaction Price: ₦7.80 per shar
Total Consideration: ₦312,000,000
Date & Venue: August 4, 2026 | Lagos, NigeriaThe notice fulfills post-transaction disclosure requirements governing insider dealings under NGX regulatory frameworks.
